A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts

Qianhe Ren(Northern Jiangsu People's Hospital), Yue Yu(Xijing Hospital), Yanlong Feng(Jiangsu Province Hospital), Xiao Zhang(Wuhan University), Haoran Lin(Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou)), Pengpeng Zhang(Tianjin Medical University Cancer Institute and Hospital), Zhijia Xia(Chongqing Medical University), Huabao Cai(Anhui Medical University), Hao Chi(Southwest Medical University)
Frontiers in Immunology
May 31, 2023
10.3389/fimmu.2023.1201573
Cited by 81

Related Papers

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
|Cell Research|2021|198
Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC
|Frontiers in Immunology|2022|178
Flavodiiron Proteins in Oxygenic Photosynthetic Organisms: Photoprotection of Photosystem II by Flv2 and Flv4 in Synechocystis sp. PCC 6803
|PLoS ONE|2009|170
T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing
|Frontiers in Immunology|2023|153